From the Division of Critical Care Medicine, Department of Anesthesia and Perioperative Care.
Department of Anesthesia and Perioperative Care.
Anesth Analg. 2020 Dec;131(6):1911-1922. doi: 10.1213/ANE.0000000000005223.
Postoperative delirium is a common and serious problem for older adults. To better align local practices with delirium prevention consensus guidelines, we implemented a 5-component intervention followed by a quality improvement (QI) project at our institution.
This hybrid implementation-effectiveness study took place at 2 adult hospitals within a tertiary care academic health care system. We implemented a 5-component intervention: preoperative delirium risk stratification, multidisciplinary education, written memory aids, delirium prevention postanesthesia care unit (PACU) orderset, and electronic health record enhancements between December 1, 2017 and June 30, 2018. This was followed by a department-wide QI project to increase uptake of the intervention from July 1, 2018 to June 30, 2019. We tracked process outcomes during the QI period, including frequency of preoperative delirium risk screening, percentage of "high-risk" screens, and frequency of appropriate PACU orderset use. We measured practice change after the interventions using interrupted time series analysis of perioperative medication prescribing practices during baseline (December 1, 2016 to November 30, 2017), intervention (December 1, 2017 to June 30, 2018), and QI (July 1, 2018 to June 30, 2019) periods. Participants were consecutive older patients (≥65 years of age) who underwent surgery during the above timeframes and received care in the PACU, compared to a concurrent control group <65 years of age. The a priori primary outcome was a composite of perioperative American Geriatrics Society Beers Criteria for Potentially Inappropriate Medication Use (Beers PIM) medications. The secondary outcome, delirium incidence, was measured in the subset of older patients who were admitted to the hospital for at least 1 night.
During the 12-month QI period, preoperative delirium risk stratification improved from 67% (714 of 1068 patients) in month 1 to 83% in month 12 (776 of 931 patients). Forty percent of patients were stratified as "high risk" during the 12-month period (4246 of 10,494 patients). Appropriate PACU orderset use in high-risk patients increased from 19% in month 1 to 85% in month 12. We analyzed medication use in 7212, 4416, and 8311 PACU care episodes during the baseline, intervention, and QI periods, respectively. Beers PIM administration decreased from 33% to 27% to 23% during the 3 time periods, with adjusted odds ratio (aOR) 0.97 (95% confidence interval [CI], 0.95-0.998; P = .03) per month during the QI period in comparison to baseline. Delirium incidence was 7.5%, 9.2%, and 8.5% during the 3 time periods with aOR of delirium of 0.98 (95% CI, 0.91-1.05, P = .52) per month during the QI period in comparison to baseline.
A perioperative delirium prevention intervention was associated with reduced administration of Beers PIMs to older adults.
术后谵妄是老年人中常见且严重的问题。为了使当地的实践与谵妄预防共识指南更好地保持一致,我们在我们的机构实施了一个 5 个组成部分的干预措施,随后进行了一个质量改进(QI)项目。
这项混合实施效果研究在一家三级保健学术医疗保健系统中的 2 家成人医院进行。我们实施了 5 个组成部分的干预措施:术前谵妄风险分层、多学科教育、书面记忆辅助、术后谵妄预防麻醉后护理单元(PACU)医嘱集和电子病历增强,时间为 2017 年 12 月 1 日至 2018 年 6 月 30 日。随后,从 2018 年 7 月 1 日到 2019 年 6 月 30 日,进行了一个部门范围的 QI 项目,以增加干预措施的使用率。在 QI 期间,我们跟踪了过程结果,包括术前谵妄风险筛查的频率、“高风险”筛查的百分比和适当的 PACU 医嘱集使用的频率。我们使用围手术期药物处方实践的中断时间序列分析,在基线(2016 年 12 月 1 日至 2017 年 11 月 30 日)、干预(2017 年 12 月 1 日至 2018 年 6 月 30 日)和 QI(2018 年 7 月 1 日至 2019 年 6 月 30 日)期间,测量了干预措施后的实践变化。参与者为在上述时间范围内接受手术并在 PACU 接受护理的连续老年患者(≥65 岁),与同期年龄<65 岁的对照组相比。预先设定的主要结果是围手术期美国老年医学会潜在不适当药物使用(Beers PIM)药物的复合结果。次要结果,谵妄发病率,在接受至少 1 晚住院治疗的老年患者亚组中进行了测量。
在 12 个月的 QI 期间,术前谵妄风险分层从第 1 个月的 67%(1068 名患者中的 714 名)提高到第 12 个月的 83%(931 名患者中的 776 名)。在 12 个月期间,40%的患者被分层为“高风险”(10494 名患者中的 4246 名)。高风险患者中适当的 PACU 医嘱集使用率从第 1 个月的 19%增加到第 12 个月的 85%。我们分别分析了 7212、4416 和 8311 个 PACU 护理事件中的药物使用情况,分别为基线、干预和 QI 期间。Beers PIM 给药从 33%降至 27%至 23%,在 QI 期间与基线相比,调整后的优势比(aOR)每月为 0.97(95%置信区间[CI],0.95-0.998;P=.03)。在 3 个时间段中,谵妄的发病率分别为 7.5%、9.2%和 8.5%,与基线相比,QI 期间的谵妄的 aOR 为每月 0.98(95%CI,0.91-1.05,P=.52)。
围手术期谵妄预防干预措施与老年患者 Beers PIM 的使用减少有关。